Alector Inc (ALEC)
4.91
-0.22
(-4.20%)
USD |
NASDAQ |
Nov 14, 16:00
4.905
0.00 (0.00%)
After-Hours: 20:00
Alector Cash from Financing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 0.00 |
June 30, 2024 | 0.644M |
March 31, 2024 | 71.11M |
December 31, 2023 | 0.59M |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.881M |
March 31, 2023 | 1.079M |
December 31, 2022 | 0.636M |
September 30, 2022 | 0.489M |
June 30, 2022 | 0.906M |
March 31, 2022 | 2.483M |
December 31, 2021 | 8.638M |
September 30, 2021 | 14.82M |
June 30, 2021 | 2.962M |
Date | Value |
---|---|
March 31, 2021 | 3.874M |
December 31, 2020 | 1.096M |
September 30, 2020 | 0.286M |
June 30, 2020 | 2.27M |
March 31, 2020 | 228.46M |
December 31, 2019 | 1.437M |
September 30, 2019 | 0.72M |
June 30, 2019 | -0.116M |
March 31, 2019 | 170.31M |
December 31, 2018 | -1.28M |
September 30, 2018 | 62.33M |
June 30, 2018 | 70.15M |
March 31, 2018 | -0.062M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2023
228.46M
Maximum
Mar 2020
17.13M
Average
1.088M
Median
Cash from Financing (Quarterly) Benchmarks
Precision BioSciences Inc | 3.733M |
NovaBay Pharmaceuticals Inc | 2.089M |
Palatin Technologies Inc | 5.991M |
iBio Inc | 12.99M |
Theriva Biologics Inc | 1.773M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -50.73M |
Cash from Investing (Quarterly) | 40.35M |
Free Cash Flow | -222.26M |
Free Cash Flow Per Share (Quarterly) | -0.5224 |
Free Cash Flow to Equity (Quarterly) | -50.95M |
Free Cash Flow to Firm (Quarterly) | -50.95M |
Free Cash Flow Yield | -48.62% |